Was sent this today via aGoogle news suggestion -
www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital.
Interesting, needs further trials, was fairly small.